WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 30th, there was short interest totaling 66,851 shares, an increase of 498.5% from the October 15th total of 11,170 shares. Based on an average daily volume of 117,526 shares, the short-interest ratio is presently 0.6 days. Approximately 0.0% of the company’s stock are sold short.
WuXi Biologics (Cayman) Stock Down 2.7%
WXXWY traded down $0.33 during midday trading on Friday, reaching $11.99. The company had a trading volume of 4,795 shares, compared to its average volume of 69,068. WuXi Biologics has a 12-month low of $7.30 and a 12-month high of $14.80. The business has a 50-day moving average price of $12.76 and a two-hundred day moving average price of $10.30.
Analysts Set New Price Targets
Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock has a consensus rating of “Hold”.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide. Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.
See Also
- Five stocks we like better than WuXi Biologics (Cayman)
- Costco’s Record $30 Dividend Shows Just How Strong Its Cash Machine Is
- Heavy Lifting: Can USA Rare Earth Turn Its First Sales Into Big Profits?
- These 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?
- Golden Dome’s $185 Billion Question: Who Actually Gets Paid?
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
